Developmental Research Program

发展研究计划

基本信息

项目摘要

ABSTRACT: Developmental Research Program (DRP) The MSCP SPORE Developmental Research Program (DRP) provides seed funding to explore promising novel research in melanoma and other skin cancers, particularly by investigators not currently engaged in research in this area. The DRP will solicit proposals 1-2 times per year and applies a peer-reviewed scoring system to prioritize the funding of 2-3 proposals per year at up to $75K/proposal/year. The DRP and SPORE Co-Directors, Regional Melanoma Consortium (RMC) representatives, and members of our SPORE Internal Advisory Board (IAB) and External Advisory Board (EAB) participate in the review process, together with Patient Advocates and any additional experts necessary to judge project feasibility, translational significance and likely overall impact. During the most recent period of funding, the MSCP SPORE supported 9 DRP projects in basic, translational, and clinical research. The DRP Co-Directors track the progress of the successful applications and assign mentors to funded investigators to ensure that they obtain any needed services from the MSCP SPORE Cores, and that they are effectively integrated into the SPORE program. Awardees present their research results to the MSCP SPORE membership after one year of funding to become eligible for a second year of support. Progress toward translation as well as impact and innovation will determine whether DRP projects are found to merit promotion to full SPORE projects at the time of formulating a renewal bid. Awardees are also advised as appropriate in the preparation of grant applications for funding outside the SPORE mechanism and given access to all SPORE Core resources to aid in this endeavor. DRP- supported research over the most recent period of support resulted in funded NIH R01, R21 and P01 grants, numerous publications and presentations at local, national and international meetings/symposia that serve to enhance MSC SPORE visibility on a global level.
摘要:发展研究计划(DRP)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Walter J. Storkus其他文献

Cellules dendritiques modifiées et utilisations pour le traitement du cancer
树突状细胞的修饰及其在癌症特性中的应用
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mark Braughler;Prasanna Kumar;Walter J. Storkus;Hideho Okada
  • 通讯作者:
    Hideho Okada
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
  • DOI:
    10.1186/s40425-018-0495-7
  • 发表时间:
    2019-01-09
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Zong Sheng Guo;Binfeng Lu;Zongbi Guo;Esther Giehl;Mathilde Feist;Enyong Dai;Weilin Liu;Walter J. Storkus;Yukai He;Zuqiang Liu;David L. Bartlett
  • 通讯作者:
    David L. Bartlett

Walter J. Storkus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Walter J. Storkus', 18)}}的其他基金

Developmental Research Program
发展研究计划
  • 批准号:
    10683763
  • 财政年份:
    2021
  • 资助金额:
    $ 7.8万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10683764
  • 财政年份:
    2021
  • 资助金额:
    $ 7.8万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10270234
  • 财政年份:
    2021
  • 资助金额:
    $ 7.8万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10469640
  • 财政年份:
    2021
  • 资助金额:
    $ 7.8万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10270235
  • 财政年份:
    2021
  • 资助金额:
    $ 7.8万
  • 项目类别:
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
项目 3:TME 中的趋化因子调节,以增强 TLS 形成和治疗性 CD8 TIL 的交叉引发/招募
  • 批准号:
    10362702
  • 财政年份:
    2020
  • 资助金额:
    $ 7.8万
  • 项目类别:
Induction of Therapeutic Immunity in the Tumor Microenvironment
肿瘤微环境中治疗性免疫的诱导
  • 批准号:
    9079574
  • 财政年份:
    2016
  • 资助金额:
    $ 7.8万
  • 项目类别:
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
针对黑色素瘤相关脉管系统的组合免疫疗法
  • 批准号:
    8720521
  • 财政年份:
    2012
  • 资助金额:
    $ 7.8万
  • 项目类别:
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
针对黑色素瘤相关脉管系统的组合免疫疗法
  • 批准号:
    8548313
  • 财政年份:
    2012
  • 资助金额:
    $ 7.8万
  • 项目类别:
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
针对黑色素瘤相关脉管系统的组合免疫疗法
  • 批准号:
    9111875
  • 财政年份:
    2012
  • 资助金额:
    $ 7.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了